Efficacy and safety of anlotinib combined with docetaxel in second-line treatment of extensive-stage small cell lung cancer

Authors
Category Primary study
JournalChinese Journal of Cancer Prevention and Treatment
Year 2023
This article has no abstract
Epistemonikos ID: 36eb8bd51c2e3860f83ef3a3b83915d58563e407
First added on: Dec 07, 2023